A detailed history of Rothschild Investment LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 115 shares of REPL stock, worth $1,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Previous 15 666.67%
Holding current value
$1,437
Previous $135,000 833.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$8.09 - $11.23 $809 - $1,123
100 Added 666.67%
115 $1.26 Million
Q2 2024

Jul 30, 2024

BUY
$5.01 - $9.46 $75 - $141
15 New
15 $135,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.